Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Cash from Investing Activities (2018 - 2025)

AdaptHealth has reported Cash from Investing Activities over the past 8 years, most recently at -$124.5 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$124.5 million for Q4 2025, down 43.28% from a year ago — trailing twelve months through Dec 2025 was -$303.2 million (up 2.28% YoY), and the annual figure for FY2025 was -$303.2 million, up 2.28%.
  • Cash from Investing Activities for Q4 2025 was -$124.5 million at AdaptHealth, down from -$92.7 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for AHCO hit a ceiling of $9.6 million in Q2 2025 and a floor of -$1.2 billion in Q1 2021.
  • Median Cash from Investing Activities over the past 5 years was -$91.6 million (2023), compared with a mean of -$160.3 million.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 2536.4% in 2021 and later surged 111.82% in 2025.
  • AdaptHealth's Cash from Investing Activities stood at -$266.2 million in 2021, then soared by 45.24% to -$145.8 million in 2022, then skyrocketed by 37.98% to -$90.4 million in 2023, then rose by 3.92% to -$86.9 million in 2024, then plummeted by 43.28% to -$124.5 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$124.5 million (Q4 2025), -$92.7 million (Q3 2025), and $9.6 million (Q2 2025) per Business Quant data.